A long-acting somatostatin analog similar to octreotide. FDA approved for acromegaly and gastroenteropancreatic neuroendocrine tumors.

Is Lanreotide FDA approved?

Yes, Lanreotide is FDA approved. FDA Approved - Acromegaly and GEP-NETs

What are the side effects of Lanreotide?

Reported side effects of Lanreotide include: Diarrhea, Abdominal pain, Nausea, Injection site reactions, Gallstones, Hyperglycemia or hypoglycemia, Bradycardia, FDA approved (Somatuline).

What is the typical dosing for Lanreotide?

FDA-approved dosing. Common doses observed in research: 60-120 mg deep SC every 4 weeks, Extended interval dosing possible. Duration: Long-term / chronic use. Administration: Deep subcutaneous injection.

Hormonal

Lanreotide

Also known as: Somatuline, Somatuline Depot

FDA Approved

Popular For

Acromegaly, neuroendocrine tumors, hormone control

Key Facts: Lanreotide

Category: Hormonal
FDA Status: FDA Approved
Clinical Status: FDA Approved - Acromegaly and GEP-NETs
Administration: Deep subcutaneous injection
Typical Dose: 60-120 mg every 4 weeks
Frequency: Every 4 weeks (deep SC)
Evidence Level: FDA Approved
Duration: Long-term / chronic use

Also Known As

Somatuline, Somatuline Depot

Mechanism of Action

Lanreotide binds preferentially to SST2 and SST5 somatostatin receptors. Inhibits GH secretion, reduces IGF-1 levels, and has antiproliferative effects on neuroendocrine tumor cells. Self-injectable deep SC formulation.

Research Summary

CLARINET trial demonstrated tumor control in GEP-NETs. Noninferior to octreotide for acromegaly. Unique self-injectable deep subcutaneous formulation improves convenience. Extended dosing interval available.

Clinical Status:FDA Approved - Acromegaly and GEP-NETs

Trial Progress:FDA Approved

Pre

III

FDA

Dosing Information

FDA Approved·Human clinical trials completed, FDA approved

Typical DosingⓘDoses commonly used by people in practice, based on community reports and anecdotal experience.

Community experience

Common Dose

60-120 mg every 4 weeks

Range

60-120 mg per injection

Frequency

Every 4 weeks (deep SC)

Long-acting somatostatin analog. Somatuline Depot. Deep subcutaneous injection.

Research DosingⓘDoses from published scientific studies and clinical trials. May include human or animal research.

Scientific studies

FDA-approved dosing

Doses from Studies

60-120 mg deep SC every 4 weeks

FDA Approved Labeling - Prescribed dose ↗

Extended interval dosing possible

FDA Approved Labeling - Prescribed dose ↗

Duration

Long-term / chronic use

Administration

Deep subcutaneous injection

Timing & Administration

Best Time to Take

Morning or as directed

Follow recommended protocol

Food Recommendation

With or without food

Why This Timing?

Timing may vary based on individual response and goals. Consistency is generally more important than specific timing.

Possible Side Effects

Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.

●Diarrhea
●Abdominal pain
●Nausea
●Injection site reactions
●Gallstones
●Hyperglycemia or hypoglycemia
●Bradycardia
●FDA approved (Somatuline)

References

Related Peptides

Peptides commonly compared with Lanreotide or used in similar applications.

Gonadorelin

FDA

A synthetic version of gonadotropin-releasing hormone. Used diagnostically and therapeutically for various reproductive and hormonal conditions.

Hormonal

Pegvisomant

FDA

A GH receptor antagonist that blocks growth hormone action. Used for acromegaly when surgery and somatostatin analogs fail to normalize IGF-1.

Hormonal

Macimorelin

FDA

An oral ghrelin mimetic used to diagnose adult growth hormone deficiency. The first FDA-approved oral GH stimulation test.

Hormonal

Oxytocin

FDA

A naturally occurring peptide hormone crucial for social bonding, childbirth, and lactation. Being studied for autism, anxiety, and social disorders.

Hormonal

Leuprolide

FDA

A GnRH agonist that suppresses testosterone and estrogen production. FDA approved for prostate cancer, endometriosis, uterine fibroids, and precocious puberty.

Hormonal

Desmopressin

FDA

A synthetic analog of vasopressin (ADH) used for diabetes insipidus, bedwetting, and bleeding disorders. Does not cause vasoconstriction like natural vasopressin.

Hormonal

How to Use Lanreotide Lanreotide Alternatives Compare with Similar Browse All Peptides

Looking for a trusted vendor?

Pro members get access to verified vendors with quality standards & exclusive discount codes.

View Verified Vendors

PRO

Want updates on Lanreotide research?

Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.

Back to all peptides